BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 8823345)

  • 1. Maintenance therapy of persons with schizophrenia.
    Carpenter WT
    J Clin Psychiatry; 1996; 57 Suppl 9():10-8. PubMed ID: 8823345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early, targeted pharmacotherapeutic intervention in schizophrenia.
    Carpenter W
    J Clin Psychiatry; 1986 May; 47 Suppl():23-9. PubMed ID: 2871012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management strategies for the treatment of schizophrenia.
    Kane JM
    J Clin Psychiatry; 1999; 60 Suppl 12():13-7. PubMed ID: 10372604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine maintenance therapy in schizophrenia.
    Gaszner P; Makkos Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):465-9. PubMed ID: 15093952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of antipsychotic drugs and family therapies in the maintenance treatment of schizophrenia.
    Schooler NR
    J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):11S-19S. PubMed ID: 2870086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of schizophrenia.
    Marder SR
    J Clin Psychiatry; 1996; 57 Suppl 3():9-13; discussion 47. PubMed ID: 8626371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic medication: clinical guidelines for maintenance therapy.
    Johnson DA
    J Clin Psychiatry; 1985 May; 46(5 Pt 2):6-15. PubMed ID: 2859281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of treatment-resistant patients with schizophrenia.
    Marder SR
    J Clin Psychiatry; 1996; 57 Suppl 11():26-30. PubMed ID: 8941168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of relapse in chronic schizophrenic patients.
    Hogarty GE
    J Clin Psychiatry; 1993 Mar; 54 Suppl():18-23. PubMed ID: 8097193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance, evaluation, and management of secondary depression in schizophrenia.
    Becker RE; Singh MM; Meisler N; Shillcutt S
    J Clin Psychiatry; 1985 Nov; 46(11 Pt 2):26-32. PubMed ID: 2865254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation.
    Raskin S; Katz G; Zislin Z; Knobler HY; Durst R
    Acta Psychiatr Scand; 2000 Apr; 101(4):334-6. PubMed ID: 10782556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
    Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological long-term treatment strategies in first episode schizophrenia--study design and preliminary results of an ongoing RCT within the German Research Network on Schizophrenia.
    Gaebel W; Möller HJ; Buchkremer G; Ohmann C; Riesbeck M; Wölwer W; Von Wilmsdorff M; Bottlender R; Klingberg S
    Eur Arch Psychiatry Clin Neurosci; 2004 Apr; 254(2):129-40. PubMed ID: 15146342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
    Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natural course of schizophrenia and effective maintenance drug treatment.
    Davis JM; Andriukaitis S
    J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):2S-10S. PubMed ID: 2870087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose response of prophylactic antipsychotics.
    Davis JM; Kane JM; Marder SR; Brauzer B; Gierl B; Schooler N; Casey DE; Hassan M
    J Clin Psychiatry; 1993 Mar; 54 Suppl():24-30. PubMed ID: 8097195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapse prevention and recovery in the treatment of schizophrenia.
    Schooler NR
    J Clin Psychiatry; 2006; 67 Suppl 5():19-23. PubMed ID: 16822093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of early warning signs in schizophrenic patients. Possible applications in prevention of recurrence].
    Wiedemann G; Hahlweg K; Hank G; Feinstein E; Müller U; Dose M
    Nervenarzt; 1994 Jul; 65(7):438-43. PubMed ID: 7800087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.